Objectives. Both results of the odor identification and cardiac123I-metaiodobenzylguanidine accumulation have been investigated for their potential to enhance the detection of pathogenesis resembling that of Lewy body-relatedα-synucleinopathies in patients clinically diagnosed as having idiopathic REM sleep behavior disorder.Methods. We performed both the Odor Stick Identification Test for Japanese and123I-metaiodobenzylguanidine scintigraphy in 30 patients with idiopathic REM sleep behavior disorder, 38 patients with Parkinson's disease, and 20 control subjects.Results. In idiopathic REM sleep behavior disorder, reduced odor identification score and an early or delayed heart to mediastinum ratio on123I-metaiodobenzylguanidine were almost as severe as in Parkinson's disease patients. Delayed cardiac123I-metaiodobenzylguanidine uptake was even more severe in the idiopathic REM sleep behavior disorder group than in the Parkinson's disease group.Conclusions. Reduced cardiac123I-metaiodobenzylguanidine uptake, which is independent of parkinsonism, may be more closely associated with idiopathic REM sleep behavior disorder than olfactory impairment.
Pareidolias in REM Sleep Behavior Disorder: A Possible Predictive Marker of Lewy Body Diseases?